Kenichi Hiramatsu

CXCR4 antagonist inhibits stromal cell-derived factor 1-induced migration and invasion of human pancreatic cancer

Tomohiko Mori, Ryuichiro Doi, Masayuki Koizumi et al. · Molecular Cancer Therapeutics · 2004 · 407 citations · Full text

Tumor Biology, Pancreatic Cancer, Medicine +12

T140 analogs as CXCR4 antagonists identified as anti‐metastatic agents in the treatment of breast cancer

Hirokazu Tamamura, Akira Hori, Naoyuki Kanzaki et al. · FEBS Letters · 2003 · 281 citations · Full text

Inhibitory Activity, T140 Analogs, Breast Oncology +14

Asymmetric Fluorination of Enamides: Access to α-Fluoroimines Using an Anionic Chiral Phase-Transfer Catalyst

Robert J. Phipps, Kenichi Hiramatsu, F. Dean Toste · Journal of the American Chemical Society · 2012 · 208 citations

Halogenation, Derivatives, Engineering +14

Molecular‐Size Reduction of a Potent CXCR4‐Chemokine Antagonist Using Orthogonal Combination of Conformation‐ and Sequence‐Based Libraries

Nobutaka Fujii, Shinya Oishi, Kenichi Hiramatsu et al. · Angewandte Chemie International Edition · 2003 · 202 citations

Peptide Engineering, Molecular Biology, Peptide Science +17

Identification of a CXCR4 antagonist, a T140 analog, as an anti‐rheumatoid arthritis agent

Hirokazu Tamamura, Miho Fujisawa, Kenichi Hiramatsu et al. · FEBS Letters · 2004 · 137 citations · Full text